Diet :: Britons working on chocolate diet pill
The British-based Chocolate Powder Company says it is testing the weight loss effects of a cocoa-based diet pill that could soon be ready for launch on the US weight loss market.
The British-based Chocolate Powder Company says it is testing the weight loss effects of a cocoa-based diet pill that could soon be ready for launch on the US weight loss market.
Think about how many times you do that during a busy day. Now, think about how before that breath has even left your body, your mind has already begun to move on to its next distraction. The calming effects of the deep breath rush out as your brain gets busy.
A protein that seems to be pivotal in lifting depression has been discovered by a Nobel Laureate researcher funded by the National Institutes of Health’s National Institute of Mental Health (NIMH).
Patients with psoriasis attending the University of Utah Dermatology Clinics were more likely to be obese and to smoke compared with nonpsoriatic patients and more likely to be obese compared with other large cohorts with psoriasis.
In a dermatology clinic of a large university-based hospital in Bangkok, Thailand, a study was conducted to determine whether targeted UV-B phototherapy is efficacious and safe in the treatment of localized psoriasis and whether there is a dose-response relationship.
Researchers studying learning disabilities associated with neurofibromatosis type 1, or NF1, have traced the problem to excessive activity of a crucial signaling molecule and have successfully reversed the disabilities in mice by giving them an experimental drug. The findings provide hope that these learning problems may one day be treatable in humans.
Lupus is caused by Natural Killer (NK) CD4– and CD8– T-Lymphocytes, also called T cells. These T cells multiply using a potassium gene channel. These same cells cause Diabetes.
Researchers at Wake Forest University School of Medicine and the University of Virginia hope to reset part of the “epigenetic code” in lupus patients.
Cancer-causing ultraviolet rays are 40 percent stronger in New Zealand than at similar latitudes in North America, research by the National Institute of Water & Atmospheric Research and the university shows. The study will be published in the next issue of the Cambridge, U.K.-based journal of Photochemical and Photobiological Sciences.
According to results recently presented at the 47th annual meeting of the American Society of Hematology (ASH), the agent GX15-070, which is still in clinical trials, has anticancer activity in patients with chronic lymphocytic leukemia (CLL) who have stopped responding to standard therapies including chemotherapy, Rituxan?, and Campath?.